An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions
Cecilia Larocca, Nicole R. LeBoeuf, Ann W. Silk, Howard L. Kaufman
Topics & Concepts
MedicineOncolytic virusMelanomaBlockadeCombination therapyClinical trialImmune checkpointOncologyImmunotherapyCancerInternal medicineCancer researchReceptorVirus-based gene therapy researchCAR-T cell therapy researchImmunotherapy and Immune Responses